![Clay Kahler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clay Kahler
Director/Board Member at
CANTON STRATEGIC HOLDINGS, INC.
Net worth: - $ as of 30/06/2026
Profile
Clay Kahler currently works at Canton Strategic Holdings, Inc., as Independent Director from 2025.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Clay Kahler active positions
| Companies | Position | Start |
|---|---|---|
| CANTON STRATEGIC HOLDINGS, INC. | Director/Board Member | 28/04/2025 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Tharimmune, Inc.
 Tharimmune, Inc. BiotechnologyHealth Technology Operates as a pre-clinical biotechnology company that develops novel therapeutic candidates targeting ferroptosis | Health Technology |
- Stock Market
- Insiders
- Clay Kahler
